Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trial

por Ali, Shaukat, Shalim, Elisha, Farhan, Farah, Anjum, Fatima, Ali, Ayesha, Uddin, Syed Muneeb, Shahab, Faisal, Haider, Mustafa, Ahmed, Iqra, Ali, Mir Rashid, Khan, Sadaf, Rao, Sadia, Guriro, Kabeer, Elahi, Saud, Ali, Muhammad, Mushtaq, Tehreem, Sayeed, Muneeba Ahsan, Muhaymin, Sheikh Muhammad, Luxmi, Shoba, Saifullah, Qureshi, Saeed
Publicado 2022